1. Home
  2. BWMN vs ENGN Comparison

BWMN vs ENGN Comparison

Compare BWMN & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BWMN

Bowman Consulting Group Ltd.

HOLD

Current Price

$31.73

Market Cap

620.2M

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$8.01

Market Cap

647.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWMN
ENGN
Founded
1995
1999
Country
United States
Canada
Employees
N/A
82
Industry
Military/Government/Technical
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
620.2M
647.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BWMN
ENGN
Price
$31.73
$8.01
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$45.50
$21.08
AVG Volume (30 Days)
91.7K
245.0K
Earning Date
05-05-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
329.41
N/A
EPS
0.73
N/A
Revenue
$490,017,000.00
N/A
Revenue This Year
$14.93
N/A
Revenue Next Year
$11.57
N/A
P/E Ratio
$42.90
N/A
Revenue Growth
14.88
N/A
52 Week Low
$21.70
$2.66
52 Week High
$45.83
$12.25

Technical Indicators

Market Signals
Indicator
BWMN
ENGN
Relative Strength Index (RSI) 58.24 53.86
Support Level $30.48 $7.83
Resistance Level $36.83 $8.14
Average True Range (ATR) 1.00 0.55
MACD 0.15 0.15
Stochastic Oscillator 87.10 54.89

Price Performance

Historical Comparison
BWMN
ENGN

About BWMN Bowman Consulting Group Ltd.

Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: